Caprion Proteomics Buys PPD Biomarker Unit

Caprion Proteomics Inc., a provider of proteomics-based service to the pharma and biotech industries, has acquired the biomarker services unit of PPD Inc. (Nasdaq: PPDI). No financial terms were disclosed. Caprion Proteomics is a portfolio company of Great Point Partners.

DealsNorth AmericaUSBriefs